2 January 2021 in Journal of the Endocrine Society
Aminoacyl-tRNA synthetases (ARSs) are crucial enzymes for protein translation. Mutations in genes encoding ARSs are associated with human disease. Tyrosyl-tRNA synthetase is encoded by YARS which is ubiquitously expressed and implicated in an autosomal dominant form of Charcot-Marie-Tooth and autosomal recessive YARS-related multisystem disease. We report on a former 34-week gestational age male who presented at 2 months of age with failure to thrive (FTT) and cholestatic hepatitis. He was subsequently diagnosed with hyperinsulinemic hypoglycemia with a negative congenital hyperinsulinism gene panel and F-DOPA positron-emission tomography (PET) scan that did not demonstrate a focal lesion. Autopsy findings were notable for overall normal pancreatic islet size and morphology. Trio whole exome sequencing identified a novel homozygous variant of uncertain significance in YARS (c.611A > C, p.Tyr204Cys) with each parent a carrier for the YARS variant. Euglycemia was maintained with diazoxide (max dose, 18 mg/kg/day), and enteral dextrose via gastrostomy tube (G-Tube). During his prolonged hospitalization, the patient developed progressive liver disease, exocrine pancreatic insufficiency, acute renal failure, recurrent infections, ichthyosis, hematologic concerns, hypotonia, and global developmental delay. Such multisystem features have been previously reported in association with pathogenic YARS mutations. Although hypoglycemia has been associated with pathogenic YARS mutations, this report provides more conclusive data that a YARS variant can cause hyperinsulinemic hypoglycemia. This case expands the allelic and clinical heterogeneity of YARS-related disease. In addition, YARS-related disease should be considered in the differential of hyperinsulinemic hypoglycemia associated with multisystem disease.
24 November 2022 in Blood
20 October 2026 in Journal of Clinical Ultrasound
Castleman disease is a rare lymphoproliferative disorder that infrequently involves the parotid gland. We report a 16‐year‐old girl with a 3‐year history of slowly progressive, painless right cheek swelling. CT and MRI showed an avidly enhancing, markedly T2‐hyperintense parotid lesion, suggesting a vascular malformation; fine‐needle aspiration yielded reactive lymphoid tissue. Contrast‐enhanced ultrasound (CEUS) demonstrated rapid, intense, homogeneous enhancement, confirming a hypervascular solid mass rather than a vascular malformation and raising suspicion for Castleman disease. Superficial parotidectomy confirmed unicentric hyaline‐vascular Castleman disease. CEUS aided differentiation of a hypervascular solid lesion from a vascular malformation and narrowed the differential.